ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia

Lymphoma trials near Austin, TX, USA:

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (APOLLO)

of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....

Enrolling
Hodgkin Lymphoma, Adult
Hodgkin Lymphoma
Drug: MT-601

Phase 1

Marker Therapeutics

Austin, Texas, United States and 6 other locations

Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy

Phase 3

Novartis
Novartis

Austin, Texas, United States and 71 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Austin, Texas, United States and 71 other locations

Locations recently updated

and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...

Enrolling
Lymphoma, Non-Hodgkin
Hodgkin Disease
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 76 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Austin, Texas, United States and 215 other locations

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...

Enrolling
Non-Hodgkin's Lymphoma
Drug: ABBV-291

Phase 1

AbbVie
AbbVie

Austin, Texas, United States and 13 other locations

in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...

Enrolling
B Cell Lymphoma
Mantle Cell Lymphoma
Drug: Sonrotoclax
Drug: Placebo

Phase 3

BeiGene
BeiGene

Round Rock, Texas, United States and 134 other locations

by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...

Active, not recruiting
Hodgkin Lymphoma
Follicular Lymphoma
Combination Product: Fruquintinib
Drug: IMT-009

Phase 1, Phase 2

Immunitas Therapeutics

Austin, Texas, United States and 8 other locations

choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....

Enrolling
Follicular Lymphoma
Drug: Golcadomide
Drug: Rituximab

Phase 3

Celgene
Celgene

Austin, Texas, United States and 159 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Active, not recruiting
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Austin, Texas, United States and 194 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems